BeOne Medicines AG (ONC)

NMS – Real vaqt narxi. Valyuta: USD

358.02

-1.25 (-0.35%)

Bozor ochiq: Aug 12, 2026, 2:52 PM EDT

359.27

0.00 (0.00%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

10.08.2026

BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration

SAN CARLOS, Calif. & REDWOOD CITY, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, and Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced a multi-part collaboration including: a clinical collaboration to evaluate drug combinations incorporating select clinical-stage oncology assets from BeOne with any of Revolution.

05.08.2026

BeOne Medicines Q2 Earnings Call Highlights

BeOne Medicines NASDAQ: ONC reported second-quarter revenue of $1.7 billion, up 30% from a year earlier, and GAAP earnings per ADS of $2.05, up 144%, as sales of its BTK inhibitor BRUKINSA continued to expand across approved indications and global markets.

05.08.2026

BeOne Medicines AG (ONC) Q2 2026 Earnings Call Transcript

05.08.2026

BeOne Medicines Ltd. - Sponsored ADR (ONC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for BeOne Medicines Ltd. - Sponsored ADR (ONC) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

05.08.2026

BeOne Medicines Announces Second Quarter 2026 Financial Results and Business Updates

SAN CARLOS, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--BeOne Medicines Ltd. announced financial results and corporate updates from the second quarter of 2026.

04.08.2026

Countdown to BeOne Medicines Ltd. - Sponsored ADR (ONC) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for BeOne Medicines Ltd. - Sponsored ADR (ONC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.

Videolar

No Data

There is no data to display

Press-relizlar

10.08.2026

BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration

05.08.2026

BeOne Medicines Announces Second Quarter 2026 Financial Results and Business Updates

SAN CARLOS, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--BeOne Medicines Ltd. announced financial results and corporate updates from the second quarter of 2026.

BeOne Medicines AG (ONC)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

BeOne Medicines AG (ONC)

BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration

BeOne Medicines Q2 Earnings Call Highlights

BeOne Medicines AG (ONC) Q2 2026 Earnings Call Transcript

BeOne Medicines Ltd. - Sponsored ADR (ONC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

BeOne Medicines Announces Second Quarter 2026 Financial Results and Business Updates

Countdown to BeOne Medicines Ltd. - Sponsored ADR (ONC) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Videolar

No Data

Press-relizlar

BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration

BeOne Medicines Announces Second Quarter 2026 Financial Results and Business Updates

BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration

BeOne Medicines Q2 Earnings Call Highlights

BeOne Medicines AG (ONC) Q2 2026 Earnings Call Transcript

BeOne Medicines Ltd. - Sponsored ADR (ONC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

BeOne Medicines Announces Second Quarter 2026 Financial Results and Business Updates

Countdown to BeOne Medicines Ltd. - Sponsored ADR (ONC) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Videolar

No Data

Press-relizlar

BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration

BeOne Medicines Announces Second Quarter 2026 Financial Results and Business Updates

Search stocks

BeOne Medicines AG (ONC)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

BeOne Medicines AG (ONC)

BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration

BeOne Medicines Q2 Earnings Call Highlights

BeOne Medicines AG (ONC) Q2 2026 Earnings Call Transcript

BeOne Medicines Ltd. - Sponsored ADR (ONC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

BeOne Medicines Announces Second Quarter 2026 Financial Results and Business Updates

Countdown to BeOne Medicines Ltd. - Sponsored ADR (ONC) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Videolar

No Data

Press-relizlar

BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration

BeOne Medicines Announces Second Quarter 2026 Financial Results and Business Updates

BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration

BeOne Medicines Q2 Earnings Call Highlights

BeOne Medicines AG (ONC) Q2 2026 Earnings Call Transcript

BeOne Medicines Ltd. - Sponsored ADR (ONC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

BeOne Medicines Announces Second Quarter 2026 Financial Results and Business Updates

Countdown to BeOne Medicines Ltd. - Sponsored ADR (ONC) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Videolar

No Data

Press-relizlar

BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration

BeOne Medicines Announces Second Quarter 2026 Financial Results and Business Updates